Skip to main content
TipRanks
Go Ultimate75% OFF

Qlife Holding AB (4HG0) AI Stock Analysis

2 Followers
DE:4HG0

Qlife Holding AB

(Frankfurt:4HG0)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Recurring consumables modelCombining diagnostic instruments with single-use cartridges or reagents can create repeat purchasing as the installed base expands. This model gives Qlife a pathway to recurring revenue and greater customer retention, provided deployments and test utilization continue to grow.
Negative Factors
Small, declining revenue baseQlife remains at a very small revenue scale while TTM sales have declined and all major profitability measures are negative. This indicates that the company has not yet achieved operating scale or a sustainable cost structure, leaving earnings highly vulnerable to execution setbacks.

Qlife Holding AB (4HG0) vs. iShares MSCI Germany ETF (EWG)

-50%0%50%100%150%200%DE:4HG0-44.86%EWG+6.23%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 2.47M
Dividend Yield
―
Average Volume (3M)
―
Price to Earnings (P/E)
-0.7
Beta (1Y)
1.33
Revenue Growth
148.68%
EPS Growth
72.59%
Country
Germany
Employees
2
Sector
Healthcare
Sector Strength
51
Industry
Medical - Devices

Qlife Holding AB Business Overview & Revenue Model

Company Description

Operating as a medical technology firm, Qlife Holding AB (publ) specializes in the production and distribution of in-vitro diagnostic instruments and their associated chemical reagents. Their flagship offering is the Egoo.Health Platform, a comprehen...

Qlife Holding AB Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

DE:4HG0 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
SE:CEVISE:CEVI83OutperformSEK 4.85B35.2115.23%1.35%1.95%-8.91%
SE:SECT.BSE:SECT.B78OutperformSEK 64.19B100.6130.26%0.70%13.94%5.70%
SE:SEZISE:SEZI55NeutralSEK 525.88M-5.39-35.44%―18.56%28.11%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
SE:ACARIXSE:ACARIX45NeutralSEK 198.23M-5.03-96.06%―40.61%32.63%
SE:SCIBSE:SCIB40UnderperformSEK 128.49M-0.68-415.20%―54.94%47.64%

* Healthcare Sector Average

Performance Comparison

-50%0%50%100%DE:4HG0SE:CEVISE:SEZISE:SCIBSE:SECT.BSE:ACARIXDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:4HG0 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:4HG0Qlife Holding AB0.06-0.06-48.70%
SE:CEVICellaVision AB203.5049.9232.50%
SE:SEZISenzime AB3.35-1.60-32.36%
SE:SCIBSciBase Holding AB9.10-10.63-53.88%
SE:SECT.BSectra AB Class B329.0049.4317.68%
SE:ACARIXAcarix AB0.16-0.12-42.60%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.